Quince Therapeutics (QNCX) Revenue & Revenue Breakdown
Quince Therapeutics Revenue Highlights
00
Quince Therapeutics Revenue by Period
Quince Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | - |
Quince Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $36.00K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | - |
Quince Therapeutics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
OVID | Ovid Therapeutics | $391.69M | $173.00K |
RVMD | Revolution Medicines | $11.58M | - |
ASMB | Assembly Biosciences | $7.16M | $6.84M |
MOLN | Molecular Partners | $7.04M | $2.74M |
ANTX | AN2 Therapeutics | - | - |
PHVS | Pharvaris | - | - |
CNTB | Connect Biopharma | - | - |
QNCX | Quince Therapeutics | - | - |
NXTC | NextCure | - | - |
TIL | Instil Bio | - | - |
PMVP | PMV Pharmaceuticals | - | - |
ACHL | Achilles Therapeutics | - | - |
MLYS | Mineralys Therapeutics | - | - |
THRD | Third Harmonic Bio | - | - |
EWTX | Edgewise Therapeutics | - | - |
NUVB | Nuvation Bio | - | $727.00K |
PEPG | PepGen | - | - |